Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G E Wilson

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Journal of Medicinal Chemistry|November 13, 2004
Influence of molecular flexibility and polar surface area metrics on oral bioavailability in the ratJing J Lu, Kimberly Crimin, Jay T Goodwin, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2016
4H-Thieno[3,2-c]chromene based inhibitors of Notum PectinacetylesteraseQiang Han, Praveen K Pabba, Joseph Barbosa, et al.
Toxicologic Pathology|March 23, 2010
Early toxicology signal generation in the mouseJeffrey A Kramer, Emily O'Neill, Megan E Phillips, et al.
Journal of Medicinal Chemistry|September 30, 2009
Novel L-xylose derivatives as selective sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetesNicole C Goodwin, Ross Mabon, Bryce A Harrison, et al.
Journal of Medicinal Chemistry|January 4, 2017
Discovery of LX2761, a Sodium-Dependent Glucose Cotransporter 1 (SGLT1) Inhibitor Restricted to the Intestinal Lumen, for the Treatment of DiabetesNicole C Goodwin, Zhi-Ming Ding, Bryce A Harrison, et al.
ACS Medicinal Chemistry Letters|January 16, 2015
Discovery and Development of LX7101, a Dual LIM-Kinase and ROCK Inhibitor for the Treatment of GlaucomaBryce A Harrison, Zheng Y Almstead, Hugh Burgoon, et al.
Bioorganic & Medicinal Chemistry Letters|October 20, 2009
5-Fluorocytosine derivatives as inhibitors of deoxycytidine kinaseJames E Tarver, Theodore C Jessop, Marianne Carlsen, et al.
Journal of Medicinal Chemistry|October 17, 2009
Novel class of LIM-kinase 2 inhibitors for the treatment of ocular hypertension and associated glaucomaBryce A Harrison, N Andrew Whitlock, Michael V Voronkov, et al.
Bioorganic & Medicinal Chemistry Letters|October 20, 2009
Lead optimization and structure-based design of potent and bioavailable deoxycytidine kinase inhibitorsTheodore C Jessop, James E Tarver, Marianne Carlsen, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Journal of Medicinal Chemistry|November 13, 2004
Influence of molecular flexibility and polar surface area metrics on oral bioavailability in the ratJing J Lu, Kimberly Crimin, Jay T Goodwin, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2016
4H-Thieno[3,2-c]chromene based inhibitors of Notum PectinacetylesteraseQiang Han, Praveen K Pabba, Joseph Barbosa, et al.
Toxicologic Pathology|March 23, 2010
Early toxicology signal generation in the mouseJeffrey A Kramer, Emily O'Neill, Megan E Phillips, et al.
Journal of Medicinal Chemistry|September 30, 2009
Novel L-xylose derivatives as selective sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetesNicole C Goodwin, Ross Mabon, Bryce A Harrison, et al.
Journal of Medicinal Chemistry|January 4, 2017
Discovery of LX2761, a Sodium-Dependent Glucose Cotransporter 1 (SGLT1) Inhibitor Restricted to the Intestinal Lumen, for the Treatment of DiabetesNicole C Goodwin, Zhi-Ming Ding, Bryce A Harrison, et al.
ACS Medicinal Chemistry Letters|January 16, 2015
Discovery and Development of LX7101, a Dual LIM-Kinase and ROCK Inhibitor for the Treatment of GlaucomaBryce A Harrison, Zheng Y Almstead, Hugh Burgoon, et al.
Bioorganic & Medicinal Chemistry Letters|October 20, 2009
5-Fluorocytosine derivatives as inhibitors of deoxycytidine kinaseJames E Tarver, Theodore C Jessop, Marianne Carlsen, et al.
Journal of Medicinal Chemistry|October 17, 2009
Novel class of LIM-kinase 2 inhibitors for the treatment of ocular hypertension and associated glaucomaBryce A Harrison, N Andrew Whitlock, Michael V Voronkov, et al.
Bioorganic & Medicinal Chemistry Letters|October 20, 2009
Lead optimization and structure-based design of potent and bioavailable deoxycytidine kinase inhibitorsTheodore C Jessop, James E Tarver, Marianne Carlsen, et al.
Pageof 8